Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602)

Rachel A. Freedman, Travis J. Dockter, Jacqueline M. Lafky, Arti Hurria, Hyman J. Muss, Harvey J. Cohen, Aminah Jatoi, M. Margaret Kemeny, Kathryn J Ruddy

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: There are multiple known individual- and practice-level barriers to enrollment of older patients with cancer to clinical trials, but little is known about how the clinical research workforce feels about potential higher-level strategy changes aimed to promote increased enrollment of older patients. Subjects, Materials, and Methods: We invited all 11,351 Alliance for Clinical Trials in Oncology (“Alliance”) members to participate in an anonymous, web-based survey to examine awareness of current accrual patterns for older patients to clinical trials, to ascertain consensus on how to tackle enrollment challenges, and to provide the impetus for high-level changes to improve clinical trial accrual of older patients with cancer. Results: During the period from February 28, 2017, to June 16, 2017, 1,146 Alliance members participated (response rate = 10%), including a national diverse sample of physicians, nurses, administrative/clinical research staff, and patient advocates with representation from community, academic, and rural sites. Overall, one third felt that >50% of clinical trial enrollees should be age ≥65, and 64.9% felt the Alliance could improve upon enrollment of older patients. The four most commonly ranked strategies to improve enrollment of older patients were creating more dedicated trials for this population (36.3%), minimizing exclusion criteria focused on comorbidity (35.5%), developing independent strategies for those aged ≥65 and for those aged ≥70 (33.2%), and requiring that most/all Alliance trials have a specific expansion cohort of older patients (30.0%). Conclusion: We anticipate that the recommendations from >1,000 Alliance members will continue to propel important strategy changes aimed to improve accrual of older patients with cancer to clinical trials. Implications for Practice: This survey of the Alliance for Clinical Trials membership sought opinions on potential, large-scale, national strategies to improve accrual of older adults with cancer. Consensus was found around multiple strategies, including creating more dedicated trials for older patients, developing less stringent eligibility criteria, and mandating expansion cohorts of older patients within broader Alliance trials. It is anticipated that the recommendations from >1,000 Alliance members will continue to propel important strategy changes aimed to improve accrual of older patients with cancer to clinical trials.

Original languageEnglish (US)
Pages (from-to)1016-1023
Number of pages8
JournalOncologist
Volume23
Issue number9
DOIs
StatePublished - Sep 1 2018

Fingerprint

Clinical Trials
Neoplasms
Surveys and Questionnaires
Rural Population
Research
Comorbidity
Nurses
Physicians
Population

Keywords

  • Accrual
  • Cancer
  • Clinical trials
  • Older adults

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Promoting Accrual of Older Patients with Cancer to Clinical Trials : An Alliance for Clinical Trials in Oncology Member Survey (A171602). / Freedman, Rachel A.; Dockter, Travis J.; Lafky, Jacqueline M.; Hurria, Arti; Muss, Hyman J.; Cohen, Harvey J.; Jatoi, Aminah; Kemeny, M. Margaret; Ruddy, Kathryn J.

In: Oncologist, Vol. 23, No. 9, 01.09.2018, p. 1016-1023.

Research output: Contribution to journalArticle

Freedman, Rachel A. ; Dockter, Travis J. ; Lafky, Jacqueline M. ; Hurria, Arti ; Muss, Hyman J. ; Cohen, Harvey J. ; Jatoi, Aminah ; Kemeny, M. Margaret ; Ruddy, Kathryn J. / Promoting Accrual of Older Patients with Cancer to Clinical Trials : An Alliance for Clinical Trials in Oncology Member Survey (A171602). In: Oncologist. 2018 ; Vol. 23, No. 9. pp. 1016-1023.
@article{c708fb1d649d420aa3b22092f7e1ad1e,
title = "Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602)",
abstract = "Background: There are multiple known individual- and practice-level barriers to enrollment of older patients with cancer to clinical trials, but little is known about how the clinical research workforce feels about potential higher-level strategy changes aimed to promote increased enrollment of older patients. Subjects, Materials, and Methods: We invited all 11,351 Alliance for Clinical Trials in Oncology (“Alliance”) members to participate in an anonymous, web-based survey to examine awareness of current accrual patterns for older patients to clinical trials, to ascertain consensus on how to tackle enrollment challenges, and to provide the impetus for high-level changes to improve clinical trial accrual of older patients with cancer. Results: During the period from February 28, 2017, to June 16, 2017, 1,146 Alliance members participated (response rate = 10{\%}), including a national diverse sample of physicians, nurses, administrative/clinical research staff, and patient advocates with representation from community, academic, and rural sites. Overall, one third felt that >50{\%} of clinical trial enrollees should be age ≥65, and 64.9{\%} felt the Alliance could improve upon enrollment of older patients. The four most commonly ranked strategies to improve enrollment of older patients were creating more dedicated trials for this population (36.3{\%}), minimizing exclusion criteria focused on comorbidity (35.5{\%}), developing independent strategies for those aged ≥65 and for those aged ≥70 (33.2{\%}), and requiring that most/all Alliance trials have a specific expansion cohort of older patients (30.0{\%}). Conclusion: We anticipate that the recommendations from >1,000 Alliance members will continue to propel important strategy changes aimed to improve accrual of older patients with cancer to clinical trials. Implications for Practice: This survey of the Alliance for Clinical Trials membership sought opinions on potential, large-scale, national strategies to improve accrual of older adults with cancer. Consensus was found around multiple strategies, including creating more dedicated trials for older patients, developing less stringent eligibility criteria, and mandating expansion cohorts of older patients within broader Alliance trials. It is anticipated that the recommendations from >1,000 Alliance members will continue to propel important strategy changes aimed to improve accrual of older patients with cancer to clinical trials.",
keywords = "Accrual, Cancer, Clinical trials, Older adults",
author = "Freedman, {Rachel A.} and Dockter, {Travis J.} and Lafky, {Jacqueline M.} and Arti Hurria and Muss, {Hyman J.} and Cohen, {Harvey J.} and Aminah Jatoi and Kemeny, {M. Margaret} and Ruddy, {Kathryn J}",
year = "2018",
month = "9",
day = "1",
doi = "10.1634/theoncologist.2018-0033",
language = "English (US)",
volume = "23",
pages = "1016--1023",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "9",

}

TY - JOUR

T1 - Promoting Accrual of Older Patients with Cancer to Clinical Trials

T2 - An Alliance for Clinical Trials in Oncology Member Survey (A171602)

AU - Freedman, Rachel A.

AU - Dockter, Travis J.

AU - Lafky, Jacqueline M.

AU - Hurria, Arti

AU - Muss, Hyman J.

AU - Cohen, Harvey J.

AU - Jatoi, Aminah

AU - Kemeny, M. Margaret

AU - Ruddy, Kathryn J

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Background: There are multiple known individual- and practice-level barriers to enrollment of older patients with cancer to clinical trials, but little is known about how the clinical research workforce feels about potential higher-level strategy changes aimed to promote increased enrollment of older patients. Subjects, Materials, and Methods: We invited all 11,351 Alliance for Clinical Trials in Oncology (“Alliance”) members to participate in an anonymous, web-based survey to examine awareness of current accrual patterns for older patients to clinical trials, to ascertain consensus on how to tackle enrollment challenges, and to provide the impetus for high-level changes to improve clinical trial accrual of older patients with cancer. Results: During the period from February 28, 2017, to June 16, 2017, 1,146 Alliance members participated (response rate = 10%), including a national diverse sample of physicians, nurses, administrative/clinical research staff, and patient advocates with representation from community, academic, and rural sites. Overall, one third felt that >50% of clinical trial enrollees should be age ≥65, and 64.9% felt the Alliance could improve upon enrollment of older patients. The four most commonly ranked strategies to improve enrollment of older patients were creating more dedicated trials for this population (36.3%), minimizing exclusion criteria focused on comorbidity (35.5%), developing independent strategies for those aged ≥65 and for those aged ≥70 (33.2%), and requiring that most/all Alliance trials have a specific expansion cohort of older patients (30.0%). Conclusion: We anticipate that the recommendations from >1,000 Alliance members will continue to propel important strategy changes aimed to improve accrual of older patients with cancer to clinical trials. Implications for Practice: This survey of the Alliance for Clinical Trials membership sought opinions on potential, large-scale, national strategies to improve accrual of older adults with cancer. Consensus was found around multiple strategies, including creating more dedicated trials for older patients, developing less stringent eligibility criteria, and mandating expansion cohorts of older patients within broader Alliance trials. It is anticipated that the recommendations from >1,000 Alliance members will continue to propel important strategy changes aimed to improve accrual of older patients with cancer to clinical trials.

AB - Background: There are multiple known individual- and practice-level barriers to enrollment of older patients with cancer to clinical trials, but little is known about how the clinical research workforce feels about potential higher-level strategy changes aimed to promote increased enrollment of older patients. Subjects, Materials, and Methods: We invited all 11,351 Alliance for Clinical Trials in Oncology (“Alliance”) members to participate in an anonymous, web-based survey to examine awareness of current accrual patterns for older patients to clinical trials, to ascertain consensus on how to tackle enrollment challenges, and to provide the impetus for high-level changes to improve clinical trial accrual of older patients with cancer. Results: During the period from February 28, 2017, to June 16, 2017, 1,146 Alliance members participated (response rate = 10%), including a national diverse sample of physicians, nurses, administrative/clinical research staff, and patient advocates with representation from community, academic, and rural sites. Overall, one third felt that >50% of clinical trial enrollees should be age ≥65, and 64.9% felt the Alliance could improve upon enrollment of older patients. The four most commonly ranked strategies to improve enrollment of older patients were creating more dedicated trials for this population (36.3%), minimizing exclusion criteria focused on comorbidity (35.5%), developing independent strategies for those aged ≥65 and for those aged ≥70 (33.2%), and requiring that most/all Alliance trials have a specific expansion cohort of older patients (30.0%). Conclusion: We anticipate that the recommendations from >1,000 Alliance members will continue to propel important strategy changes aimed to improve accrual of older patients with cancer to clinical trials. Implications for Practice: This survey of the Alliance for Clinical Trials membership sought opinions on potential, large-scale, national strategies to improve accrual of older adults with cancer. Consensus was found around multiple strategies, including creating more dedicated trials for older patients, developing less stringent eligibility criteria, and mandating expansion cohorts of older patients within broader Alliance trials. It is anticipated that the recommendations from >1,000 Alliance members will continue to propel important strategy changes aimed to improve accrual of older patients with cancer to clinical trials.

KW - Accrual

KW - Cancer

KW - Clinical trials

KW - Older adults

UR - http://www.scopus.com/inward/record.url?scp=85052191178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052191178&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.2018-0033

DO - 10.1634/theoncologist.2018-0033

M3 - Article

C2 - 29674441

AN - SCOPUS:85052191178

VL - 23

SP - 1016

EP - 1023

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 9

ER -